Adams Asset Advisors, LLC Abb Vie Inc. Transaction History

Adams Asset Advisors, LLC

$750 Million
Q1 2024

A detailed history of Adams Asset Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Adams Asset Advisors, LLC holds 71,809 shares of ABBV stock, worth $11.9 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares

71,809

Previous 72,171 0.5%

Holding current value

$11.9 Million

Previous $11.2 Million 16.92%

% of portfolio

1.74%

Previous 1.55%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	SELL	$159.82 - $182.1 $57,854 - $65,920	-362 Reduced 0.5%	71,809 $13.1 Million
Q4 2023 Jan 12, 2024	BUY	$137.6 - $154.97 $169,110 - $190,458	1,229 Added 1.73%	72,171 $11.2 Million
Q3 2023 Oct 11, 2023	BUY	$133.59 - $154.65 $812,227 - $940,272	6,080 Added 9.37%	70,942 $10.6 Million
Q2 2023 Jul 14, 2023	BUY	$132.51 - $164.9 $8.59 Million - $10.7 Million	64,862 New	64,862 $8.74 Million
Q4 2022 Jan 13, 2023	SELL	$138.31 - $165.87 $17,427 - $20,899	-126 Reduced 0.17%	74,870 $0

Q3 2022 Oct 12, 2022	BUY	$134.21 - $153.93 $37,578 - $43,100	280 Added 0.37%	74,996 $10.1 Million
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $784,434 - $997,272	5,700 Added 8.26%	74,716 $11.4 Million
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $643,138 - $797,953	-4,873 Reduced 6.6%	69,016 $11.2 Million
Q4 2021 Jan 12, 2022	SELL	$107.43 - $135.93 $34,055 - $43,089	-317 Reduced 0.43%	73,889 $10 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $532,957 - $604,987	5,009 Added 7.24%	74,206 $8 Million
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $652,828 - $727,288	6,205 Added 9.85%	69,197 $7.79 Million
Q1 2021 Apr 12, 2021	SELL	$102.3 - $112.62 $1.35 Million - $1.48 Million	-13,177 Reduced 17.3%	62,992 $6.82 Million
Q4 2020 Jan 22, 2021	SELL	$80.49 - $108.67 $576,952 - $778,946	-7,168 Reduced 8.6%	76,169 $8.16 Million
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $763,357 - $1.16 Million	11,835 Added 16.55%	83,337 $6.35 Million
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $664,027 - $1.01 Million	-10,295 Reduced 12.59%	71,502 $5.45 Million
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $348,748 - $436,358	4,835 Added 6.28%	81,797 $7.24 Million
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $251,101 - $301,895	3,987 Added 5.46%	76,962 $5.83 Million
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $212,013 - $271,003	3,227 Added 4.63%	72,975 $5.31 Million
Q1 2019 Apr 10, 2019	BUY	$77.14 - $90.79 $73,977 - $87,067	959 Added 1.39%	69,748 $5.62 Million
Q4 2018 Jan 10, 2019	BUY	$77.85 - $96.01 $539,033 - $664,773	6,924 Added 11.19%	68,789 $6.34 Million
Q3 2018 Oct 16, 2018	BUY	$88.91 - $98.84 $5.5 Million - $6.11 Million	61,865 New	61,865 $5.85 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adams Asset Advisors, LLC with notifications on news.

Account

Adams Asset Advisors, LLC Abb Vie Inc. Transaction History